002412 Hunan Hansen Pharmaceutical
- 5.82
- +0.06+1.04%
Hunan Hansen Pharmaceutical News
Hanson Pharmaceuticals: Investor Relations Activity Record Form October 10, 2024
Hanson Pharmaceuticals: Announcement on Participating in the 2024 Annual Investor Online Group Reception Day Event in Hunan
Hunan Hansen Pharmaceutical: Financial Report for the first half of 2024.
Hunan Hansen Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Hunan Hansen Pharmaceutical: Summary of Half-Year Report in 2024.
Hunan Hansen Pharmaceutical: Half-year report for the year 2024.
Hunan Hansen Pharmaceutical: Announcement Regarding Changes to the Company's Pharmaceutical Production License
Hunan Hansen Pharmaceutical: Investor Relations Activity Record Form for ****, 2024.
Hunan Hansen Pharmaceutical: Announcement on Iodopamol injection passing the consistency evaluation
Hunan Hansen Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hunan Hansen Pharmaceutical: Legal Opinion of Hunan Qiyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Hunan Hanson Pharmaceutical Co., Ltd.
Hunan Hansen Pharmaceutical: May 17, 2024 Investor Relations Activity Record Form (2023 Online Results Briefing)
Hunan Hansen Pharmaceutical: Announcement on holding the 2023 Online Results Briefing
Hunan Hansen Pharmaceutical: Notice on convening the 2023 Annual General Meeting of Shareholders
Hunan Hansen Pharmaceutical: Administrative Measures on Institutional Research Reception Work (April 2024)
Hunan Hansen Pharmaceutical: 2023 ANNUAL REPORT
Hunan Hansen Pharmaceutical: Independent Director Work System (April 2024)
Hunan Hansen Pharmaceutical: Nomination Committee Rules of Procedure (April 2024)
Hunan Hansen Pharmaceutical: 2023 Independent Director Debriefing Report (Zhan Ping)
Hunan Hansen Pharmaceutical: Internal Audit System (April 2024)
Analysis
Price Target
No Data
No Data